Molina Healthcare Inc
NYSE:MOH

Watchlist Manager
Molina Healthcare Inc Logo
Molina Healthcare Inc
NYSE:MOH
Watchlist
Price: 298.14 USD 1.59% Market Closed
Market Cap: 16.2B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one MOH stock under the Base Case scenario is 551.91 USD. Compared to the current market price of 298.14 USD, Molina Healthcare Inc is Undervalued by 46%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MOH Relative Value
Base Case
551.91 USD
Undervaluation 46%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.4
P/S
P/S
Price to Sales
0.4
vs History
98
vs Industry
81
Median 3Y
0.6
Median 5Y
0.6
Industry
2.2
Forward
0.4
More Details
13.7
P/E
P/E
Price to Earnings
13.7
vs History
96
vs Industry
33
Median 3Y
19.2
Median 5Y
19.4
Industry
21.9
Forward
12
More Details
26
P/OCF
P/OCF
Price to OCF
26
vs History
20
vs Industry
13
Median 3Y
13.5
Median 5Y
12.3
Industry
14
More Details
8.4
P/FCFE
P/FCFE
Price to FCFE
8.4
vs History
74
vs Industry
28
Median 3Y
13.7
Median 5Y
11
Industry
19.7
More Details
3.7
P/B
P/B
Price to Book Value
3.7
vs History
93
vs Industry
21
Median 3Y
4.9
Median 5Y
5.4
Industry
2.1
More Details
0.3
EV/S
EV/S
Enterprise Value to Sales
0.3
vs History
98
vs Industry
86
Median 3Y
0.4
Median 5Y
0.4
Industry
2.3
Forward
0.2
More Details
1.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.7
vs History
98
vs Industry
71
Median 3Y
2.4
Median 5Y
2.5
Industry
4.8
More Details
5.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
5.5
vs History
98
vs Industry
44
Median 3Y
6.9
Median 5Y
7.4
Industry
11.5
Forward
5.1
More Details
6.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
6.2
vs History
98
vs Industry
43
Median 3Y
7.7
Median 5Y
8.1
Industry
15.7
Forward
5.7
More Details
17.1
EV/OCF
EV/OCF
Enterprise Value to OCF
17.1
vs History
25
vs Industry
22
Median 3Y
9.6
Median 5Y
8
Industry
14
More Details
20.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
20.1
vs History
22
vs Industry
22
Median 3Y
10.2
Median 5Y
8.6
Industry
17.4
More Details
1.8
EV/IC
EV/IC
Enterprise Value to IC
1.8
vs History
98
vs Industry
35
Median 3Y
2.8
Median 5Y
3.2
Industry
1.8
More Details

Multiples Across Competitors

MOH Competitors Multiples
Molina Healthcare Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Molina Healthcare Inc
NYSE:MOH
16.1B USD 0.4 13.7 5.5 6.2
US
UnitedHealth Group Inc
NYSE:UNH
286.8B USD 0.7 13 8.6 9.7
US
Anthem Inc
LSE:0HG8
99.4B USD 0.5 16.8 11.5 13.3
US
Elevance Health Inc
NYSE:ELV
86.8B USD 0.5 14.7 10.3 11.9
US
Humana Inc
NYSE:HUM
28.4B USD 0.2 16.6 8.1 10.2
US
Centene Corp
NYSE:CNC
27.5B USD 0.2 8 5.8 7.9
US
Healthequity Inc
NASDAQ:HQY
9.1B USD 7.3 74.6 24.3 40.5
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
19.2B BRL 1.1 -36.3 7.3 14.1
US
Magellan Health Inc
F:MAH1
2.2B EUR 0.5 8.4 12.8 38.2
US
Progyny Inc
NASDAQ:PGNY
1.8B USD 1.5 34.3 20.2 21.1
US
Clover Health Investments Corp
NASDAQ:CLOV
1.5B USD 1 -58.2 -56.8 -53.4
P/E Multiple
Earnings Growth PEG
US
Molina Healthcare Inc
NYSE:MOH
Average P/E: 22.2
13.7
15%
0.9
US
UnitedHealth Group Inc
NYSE:UNH
13
26%
0.5
US
A
Anthem Inc
LSE:0HG8
16.8
20%
0.8
US
Elevance Health Inc
NYSE:ELV
14.7
20%
0.7
US
Humana Inc
NYSE:HUM
16.6
30%
0.6
US
Centene Corp
NYSE:CNC
8
11%
0.7
US
Healthequity Inc
NASDAQ:HQY
74.6
69%
1.1
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Negative Multiple: -36.3 N/A N/A
US
M
Magellan Health Inc
F:MAH1
8.4
N/A N/A
US
Progyny Inc
NASDAQ:PGNY
34.3
36%
1
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -58.2 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Molina Healthcare Inc
NYSE:MOH
Average EV/EBITDA: 11.4
5.5
9%
0.6
US
UnitedHealth Group Inc
NYSE:UNH
8.6
7%
1.2
US
A
Anthem Inc
LSE:0HG8
11.5
11%
1
US
Elevance Health Inc
NYSE:ELV
10.3
11%
0.9
US
Humana Inc
NYSE:HUM
8.1
8%
1
US
Centene Corp
NYSE:CNC
5.8
5%
1.2
US
Healthequity Inc
NASDAQ:HQY
24.3
26%
0.9
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
7.3
20%
0.4
US
M
Magellan Health Inc
F:MAH1
12.8
N/A N/A
US
Progyny Inc
NASDAQ:PGNY
20.2
55%
0.4
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -56.8 N/A N/A

See Also

Summary
MOH intrinsic value, competitors valuation, and company profile.
DCF Valuation
MOH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MOH stock valuation using valuation multiples.
Wall Street Estimates
MOH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MOH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 261,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.